Chemoinformaics analysis of Chlorophyllide a
| Molecular Weight | 614.985 | nRot | 6 |
| Heavy Atom Molecular Weight | 580.713 | nRig | 35 |
| Exact Molecular Weight | 614.238 | nRing | 6 |
| Solubility: LogS | -3.78 | nHRing | 5 |
| Solubility: LogP | 4 | No. of Aliphatic Rings | 5 |
| Acid Count | 3 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 8 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 5 |
| nHA | 8 | APOL | 100.131 |
| nHD | 0 | BPOL | 42.8738 |
| QED | 0.235 |
| Synth | 7.27 |
| Natural Product Likeliness | 0.311 |
| NR-PPAR-gamma | 0.088 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.493 |
| Pgp-sub | 0.06 |
| HIA | 0.199 |
| CACO-2 | -5.864 |
| MDCK | 0.00000513 |
| BBB | 0.011 |
| PPB | 0.995006 |
| VDSS | 0.451 |
| FU | 0.022007 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.323 |
| CYP2c19-sub | 0.316 |
| CYP2c9-inh | 0.913 |
| CYP2c9-sub | 0.227 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.817 |
| CYP3a4-sub | 0.908 |
| CL | 1.917 |
| T12 | 0.664 |
| hERG | 0.48 |
| Ames | 0.751 |
| ROA | 0.987 |
| SkinSen | 0.941 |
| Carcinogencity | 0.882 |
| EI | 0.012 |
| Respiratory | 0.988 |
| NR-Aromatase | 0.914 |
| Antiviral | Yes |
| Prediction | 0.642213 |